Sichuan Huiyuan Optical Communications (000586.SZ): Termination of issuance of shares to specific parties, change of control, management buyout matters.
Huanyuan Communication (000586.SZ) announced that after disclosing the plan to issue shares to specific objects in the 2025 fiscal year, the company actively promoted the related work for application and issuance. Considering the current macroeconomic environment, changes in the capital market environment, and the actual situation of the company, after thorough communication and careful analysis with relevant parties, it has been decided to terminate the issuance of shares to specific objects, change of control, management acquisition, and to apply for the withdrawal of related application documents from the Shenzhen Stock Exchange, while also signing relevant termination agreements.
Sichuan Huiyuan Optical Communications (000586.SZ) announced that after disclosing the plan to issue shares to specific investors in 2025, the company has actively promoted the application for issuance. After considering various factors such as the current macroeconomic environment, changes in the capital market environment, and the company's actual situation, and after thorough communication and careful analysis with relevant parties, it has been decided to terminate the issuance of shares to specific investors, change in controlling interest, management buyout, and to apply to the SZSE to withdraw the relevant application documents, while also signing related termination agreements.
Related Articles

On May 29, HORIZONROBOT-W (09660) spent 117 million Hong Kong dollars to repurchase 22.0998 million shares.

MIRXES-B(02629): Zeng Guowei appointed as independent non-executive director

CARSGEN-B(02171): The research results of Surjotiron's injection were displayed as a poster at the 2026 ASCO Annual Meeting.
On May 29, HORIZONROBOT-W (09660) spent 117 million Hong Kong dollars to repurchase 22.0998 million shares.

MIRXES-B(02629): Zeng Guowei appointed as independent non-executive director

CARSGEN-B(02171): The research results of Surjotiron's injection were displayed as a poster at the 2026 ASCO Annual Meeting.






